This indicates that acetoxystachybotrydial acetate is a more potent inhibitor of tumor cell proliferation, at least in the case of MCF7 breast cancer cells, than the known inhibitor of human protein kinase CK2, emodin. Here, CSNK2A1 is linked to breast carcinoma.